Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 3 13Phase 1 5Phase 2/3 4Phase 1/2 1

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 35INDUSTRY 16NETWORK 4OTHER_GOV 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Breast 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 7Radiotherapy 6Vincristine 5Etoposide 5Cyclophosphamide 5Cisplatin 5Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Gemcitabine 4Doxorubicin 4Carboplatin 4Capecitabine 4pembrolizumab 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Prednisone 3Oxaliplatin 3Methotrexate 3Leucovorin 3Fluorouracil 3Dexamethasone 3Cytarabine 3Calcium Dobesilate 3Surgical Procedures, Operative 2Ramucirumab 2Radiation 2Pemetrexed 2Mitomycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Capecitabine × Clear all
NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting
574 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01196260 2018-02-20

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

State Key Laboratory of Cancer Biology

Phase 2/3 Unknown
8,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00049660 2012-07-18

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
47 enrolled
Breast

Breast Neoplasms

NCT00294359 2007-08-22

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Completed
333 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡